| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $124.5M | +44.6% |
| SG&A Expense | $17.7M | -5.7% |
| Operating Income | -$142.3M | -35.5% |
| Income Tax | $2K | +0.0% |
| Net Income | -$129.5M | -34.0% |
| EPS (Basic) | -$2.20 | -2.8% |
| EPS (Diluted) | -$2.20 | -2.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.5M | +103.5% |
| Short-term Investments | $294.6M | +52.4% |
| Current Assets | $438.5M | +64.5% |
| Total Assets | $451.0M | +62.8% |
| Current Liabilities | $41.8M | +93.1% |
| Total Liabilities | $42.0M | +82.3% |
| Stockholders' Equity | $409.0M | +61.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.4M | -24.6% |
| Capital Expenditures | $159K | — |
| Investing Cash Flow | -$93.5M | -1828.0% |
| Financing Cash Flow | $268.8M | +101.5% |
| Free Cash Flow | -$104.5M | — |